BACKGROUND: To measure hippocampal volume change in Alzheimer's disease (AD) or mild cognitive impairment (MCI), expert manual delineation is often used because of its supposed accuracy. It has been suggested that expert outlining yields poorer reproducibility as compared to automated methods, but this has not been investigated.AIM: To determine the reproducibilities of expert manual outlining and two common automated methods for measuring hippocampal atrophy rates in healthy aging, MCI and AD.METHODS: From the Alzheimer's Disease Neuroimaging Initiative (ADNI), 80 subjects were selected: 20 patients with AD, 40 patients with mild cognitive impairment (MCI) and 20 healthy controls (HCs). Left and right hippocampal volume change between base...
International audienceGrowing interest has developed in hippocampal subfield volumetry over the past...
Volume and change in volume of the hippocampus are both important markers of Alzheimer's disease (AD...
Objective: Alzheimer’s disease (AD) pathology is thought to begin years before symptom onset. Hippoc...
BACKGROUND: To measure hippocampal volume change in Alzheimer's disease (AD) or mild cognitive impai...
Background: To measure hippocampal volume change in Alzheimer's disease (AD) or mild cognitive impai...
MRI-based hippocampal volume analysis has been extensively employed given its potential as a biomark...
Purpose: Precise and reproducible hippocampus outlining is important to quantify hippocampal atrophy...
MRI-derived rates of hippocampal atrophy may serve as surrogate markers of disease progression in mi...
The purpose of this study is to assess the reproducibility of hippocampal atrophy rate measurements ...
PURPOSE:Precise and reproducible hippocampus outlining is important to quantify hippocampal atrophy ...
MRI-derived rates of hippocampal atrophy may serve as surrogate markers of disease progression in mi...
Hippocampal volume is a core biomarker of Alzheimer's disease (AD). However, its contribution over t...
Purpose Objective quantification of brain structure can aid diagnosis and therapeutic monitoring in ...
Hippocampal volume is a core biomarker of Alzheimer's disease (AD). However, its contribution over t...
Hippocampal atrophy rates have been used in a number of studies in Alzheimer's disease (AD) to asses...
International audienceGrowing interest has developed in hippocampal subfield volumetry over the past...
Volume and change in volume of the hippocampus are both important markers of Alzheimer's disease (AD...
Objective: Alzheimer’s disease (AD) pathology is thought to begin years before symptom onset. Hippoc...
BACKGROUND: To measure hippocampal volume change in Alzheimer's disease (AD) or mild cognitive impai...
Background: To measure hippocampal volume change in Alzheimer's disease (AD) or mild cognitive impai...
MRI-based hippocampal volume analysis has been extensively employed given its potential as a biomark...
Purpose: Precise and reproducible hippocampus outlining is important to quantify hippocampal atrophy...
MRI-derived rates of hippocampal atrophy may serve as surrogate markers of disease progression in mi...
The purpose of this study is to assess the reproducibility of hippocampal atrophy rate measurements ...
PURPOSE:Precise and reproducible hippocampus outlining is important to quantify hippocampal atrophy ...
MRI-derived rates of hippocampal atrophy may serve as surrogate markers of disease progression in mi...
Hippocampal volume is a core biomarker of Alzheimer's disease (AD). However, its contribution over t...
Purpose Objective quantification of brain structure can aid diagnosis and therapeutic monitoring in ...
Hippocampal volume is a core biomarker of Alzheimer's disease (AD). However, its contribution over t...
Hippocampal atrophy rates have been used in a number of studies in Alzheimer's disease (AD) to asses...
International audienceGrowing interest has developed in hippocampal subfield volumetry over the past...
Volume and change in volume of the hippocampus are both important markers of Alzheimer's disease (AD...
Objective: Alzheimer’s disease (AD) pathology is thought to begin years before symptom onset. Hippoc...